FDA Panel Offers Tempered Support For NovoCure's Brain Tumor Device
This article was originally published in The Gray Sheet
Executive Summary
An FDA advisory panel offered tempered support for NovoCure's NovoTTF-100A electric-field-based brain tumor treatment system, despite reservations about pivotal study design and analysis.